| Zacks Company Profile for STERIS plc (STE : NYSE) |
|
|
| |
| • Company Description |
| STERIS plc, develops, manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. On Nov 2, 2015, STERIS completed the acquisition of Synergy Health plc following which it was re-registered under the name ' STERIS plc. Currently, STERIS serves healthcare, pharmaceutical, research, industrial and governmental customers across the globe. The majority of STERIS' revenues is derived from the healthcare and pharmaceutical industries. STERIS provides its products and services in more than 60 countries. The company's key areas of strategic focus include developing its customer base in Europe, the Middle East and the Asia Pacific region.
Number of Employees: 13,000 |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $221.63 |
Daily Weekly Monthly
 |
| 20 Day Moving Average: 486,454 shares |
| Shares Outstanding: 100.13 (millions) |
| Market Capitalization: $22,191.19 (millions) |
| Beta: 0.67 |
| 52 Week High: $255.93 |
| 52 Week Low: $188.10 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
-10.40% |
-2.22% |
| 12 Week |
-3.37% |
1.73% |
| Year To Date |
-8.95% |
6.14% |
|
|
|
|
| |
|
|
| |
| • General Corporate Information |
Officers
Walter M Rosebrough - Chief Executive Officer;President
Mohsen M. Sohi - Chairman and Director
Michael J. Tokich - Senior Vice President and Chief Financial Officer
Karen L. Burton - Vice President; Controller and Chief Accounting Of
Richard C. Breeden - Director
|
|
Peer Information
STERIS plc (ABMD)
STERIS plc (DMDS)
STERIS plc (CPWY.)
STERIS plc (EQUR)
STERIS plc (ECIA)
STERIS plc (FMS)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: G8473T100
SIC: 3842
|
|
Fiscal Year
Fiscal Year End: March
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/08/22
|
|
Share - Related Items
Shares Outstanding: 100.13
Most Recent Split Date: 8.00 (2.00:1)
Beta: 0.67
Market Capitalization: $22,191.19 (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: 0.78% |
| Current Fiscal Quarter EPS Consensus Estimate: $1.86 |
Indicated Annual Dividend: $1.72 |
| Current Fiscal Year EPS Consensus Estimate: $8.71 |
Payout Ratio: 0.22 |
| Number of Estimates in the Fiscal Year Consensus: 2.00 |
Change In Payout Ratio: -0.05 |
| Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: 02/24/2022 - $0.43 |
| Next EPS Report Date: 08/08/22 |
|
|
|
| |
